HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Trageser Selected Research

Daniel Trageser Research Topics

Disease

5Glioblastoma (Glioblastoma Multiforme)
01/2017 - 06/2011
4Neoplasms (Cancer)
01/2017 - 08/2009
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2015 - 10/2007
1Brain Neoplasms (Brain Tumor)
08/2013
1Melanoma (Melanoma, Malignant)
06/2013
1Glioma (Gliomas)
06/2013
1Carcinogenesis
01/2012
1Philadelphia Chromosome
08/2009
1Leukemia
10/2007
1Lymphoma (Lymphomas)
10/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2007

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2017 - 06/2013
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2011 - 08/2009
2Phosphotransferases (Kinase)IBA
08/2009 - 10/2007
1Drug CombinationsIBA
01/2017
1CytokinesIBA
07/2015
1Biomarkers (Surrogate Marker)IBA
08/2013
1Temozolomide (Temodar)FDA LinkGeneric
08/2013
1NiclosamideFDA Link
08/2013
1Antiviral Agents (Antivirals)IBA
06/2013
1Nucleic AcidsIBA
06/2013
1Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2013
1Biological ProductsIBA
01/2012
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2012
1Transcription Factors (Transcription Factor)IBA
06/2011
1DNA (Deoxyribonucleic Acid)IBA
06/2011
1Pre-B Cell ReceptorsIBA
08/2009
1src-Family KinasesIBA
08/2009
1nilotinibFDA Link
10/2007
1Imatinib Mesylate (Gleevec)FDA Link
10/2007
1bcr-abl Fusion ProteinsIBA
10/2007

Therapy/Procedure

2Therapeutics
08/2013 - 10/2007
1Drug Therapy (Chemotherapy)
08/2013